Literature DB >> 21520197

Distributive justice and the arrival of direct-acting antivirals: who should be first in line?

Andrew Aronsohn1, Donald Jensen.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21520197     DOI： 10.1002/hep.24374

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  Hepatitis C virus infection: from margin to center in rhode island and beyond.

Authors:  Lynn E Taylor
Journal:  R I Med J (2013)       Date:  2014-07-01

2.  Direct-acting antiviral agents in patients with hepatitis C cirrhosis.

Authors:  Gene Y Im; Douglas T Dieterich
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-11

3.  Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program.

Authors:  Jackie Habchi; Aurielle M Thomas; Sophie Sprecht-Walsh; Elenita Arias; Jeffrey Bratberg; Linda Hurley; Susan Hart; Lynn E Taylor
Journal:  Open Forum Infect Dis       Date:  2020-10-13       Impact factor: 3.835

Review 4.  Emerging concepts in immunity to hepatitis C virus infection.

Authors:  Hugo R Rosen
Journal:  J Clin Invest       Date:  2013-10-01       Impact factor: 14.808

Review 5.  Natural killer cells: multifaceted players with key roles in hepatitis C immunity.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

6.  Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort.

Authors:  Katherine R Smith; Vijayaprakash Suppiah; Kate O'Connor; Thomas Berg; Martin Weltman; Maria Lorena Abate; Ulrich Spengler; Margaret Bassendine; Gail Matthews; William L Irving; Elizabeth Powell; Stephen Riordan; Golo Ahlenstiel; Graeme J Stewart; Melanie Bahlo; Jacob George; David R Booth
Journal:  Genome Med       Date:  2011-08-31       Impact factor: 11.117

7.  Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience.

Authors:  Alessandra Mangia; Giovanni Cenderello; Alessandra Orlandini; Valeria Piazzolla; Antonio Picciotto; Massimo Zuin; Alessia Ciancio; Giuseppina Brancaccio; Paolo Forte; Vito Carretta; Anna Linda Zignego; Nicola Minerva; Gaetano Brindicci; Massimo Marignani; Gianluca Svegliati Baroni; Gaetano Bertino; Giuseppe Cuccorese; Leonardo Mottola; Maria Ripoli; Mario Pirisi
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.